Subscribe To

Price Alert Latest News Economic Calendar News

NARI / Inari Medical to Announce Second Quarter 2022 Financial Results

IRVINE, Calif., July 18, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today that it will release its second quarter 2022 financial results on Wednesday, August 3, 2022. In conjunction with the release, Inari will host a conference call and webcast at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time to discuss its financial results and recent highlights. Read More

Demo Live Account See Partner Details

Content Topics

Inari

Medical

Announce

Second

Quarter

2022

Financial

Results

Stock

NARI

Posted: Jul 18 2022, 16:01

Author Name: GlobeNewsWire

NARI News

By Zacks Investment Research
November 3, 2023

Inari Medical (NARI) Q3 Earnings and Revenues Beat Estimates

Inari Medical's (NARI) third-quarter results benefit from strong product adoption and geographical performances.

By GlobeNewsWire
November 2, 2023

Inari Medical to Present at Upcoming Investor Conferences

IRVINE, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat a

By Seeking Alpha
November 1, 2023

Inari Medical, Inc. (NARI) Q3 2023 Earnings Call Transcript

Inari Medical, Inc. (NASDAQ:NARI ) Q3 2023 Earnings Conference Call November 1, 2023 4:30 PM ET Company Participants John Hsu - VP, IR Drew Hykes - Pr

By GlobeNewsWire
October 11, 2023

Inari Medical to Announce Third Quarter 2023 Financial Results

IRVINE, Calif., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat a

By Zacks Investment Research
October 6, 2023

Reasons to Add Inari Medical (NARI) Stock to Your Portfolio

Inari Medical (NARI) continues to benefit from its commitment to understand the venous system. However, its dependency on adoption of products is a co

By Zacks Investment Research
August 10, 2023

Wall Street Analysts See a 36.39% Upside in Inari Medical, Inc. (NARI): Can the Stock Really Move This High?

The consensus price target hints at a 36.4% upside potential for Inari Medical, Inc. (NARI). While empirical research shows that this sought-after met

By Zacks Investment Research
August 4, 2023

Inari Medical (NARI) Q2 Earnings Top, Revenues Rise Y/Y

Inari Medical's (NARI) second-quarter results benefit from significant progress made across all its growth drivers.

By The Motley Fool
August 3, 2023

Why Shares of Inari Medical Are Up Thursday

The medical device maker boosted its revenue and returned to the black on net income. Management said it benefited from the launch of two new products

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.